Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes | Zendy

Tadashi Imafuku | Zendy; Hiroshi Watanabe | Zendy; Kentaro Oniki | Zendy; Akira Yoshida | Zendy; Hiromasa Kato | Zendy; Takehiro Nakano | Zendy; Kai Tokumaru | Zendy; Issei Fujita | Zendy; Nanaka Arimura | Zendy; Hitoshi Maeda | Zendy; Yuki Sakamoto | Zendy; Nozomi Kondo | Zendy; Ayami Morita | Zendy; Junji Saruwatari | Zendy; Motoko Tanaka | Zendy; Kazutaka Matsushita | Zendy; Takashi Wada | Zendy; Masafumi Fukagawa | Zendy; Masaki Otagiri | Zendy; Michael L. Fitzgerald | Zendy; Hideaki Jinnouchi | Zendy; Toru Maruyama | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes

Author(s) -

Tadashi Imafuku,

Hiroshi Watanabe,

Kentaro Oniki,

Akira Yoshida,

Hiromasa Kato,

Takehiro Nakano,

Kai Tokumaru,

Issei Fujita,

Nanaka Arimura,

Hitoshi Maeda,

Yuki Sakamoto,

Nozomi Kondo,

Ayami Morita,

Junji Saruwatari,

Motoko Tanaka,

Kazutaka Matsushita,

Takashi Wada,

Masafumi Fukagawa,

Masaki Otagiri,

Michael L. Fitzgerald,

Hideaki Jinnouchi,

Toru Maruyama

Publication year - 2021

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc20-3003

Subject(s) - medicine , albuminuria , renal function , diabetes mellitus , kidney disease , diabetic nephropathy , type 2 diabetes , creatinine , biomarker , nephropathy , urology , albumin , endocrinology , gastroenterology , biochemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research